Gefitinib vs Rivaroxaban

Gefitinib vs Rivaroxaban: Overview

This comparison examines the pharmacological differences between Gefitinib and Rivaroxaban.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Rivaroxaban: Direct Factor Xa inhibitor.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Rivaroxaban — 5-9 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Rivaroxaban — C19H18ClN3O5S.

Molecular Weight: Gefitinib — 446.9000 g/mol; Rivaroxaban — 435.8820 g/mol.

Type: Gefitinib — Small molecule; Rivaroxaban — Small molecule.